GREAT TREE PHARMACY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 279.5 TWD | -1.41% |
|
-0.53% | -20.03% |
| 03-04 | Great Tree Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-27 | Great Tree Pharmacy Co., Ltd. Cash Dividend for the Year 2023 | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,078 | 15,725 | 26,339 | 39,040 | 31,454 | - | - |
| Enterprise Value (EV) 1 | 5,078 | 15,725 | 26,339 | 39,040 | 29,711 | 28,646 | 30,467 |
| P/E ratio | 26.6 x | 40.2 x | 38.9 x | 60.6 x | 42.6 x | 30.3 x | 27.9 x |
| Yield | - | - | 1.59% | - | 1.5% | 1.83% | 2.16% |
| Capitalization / Revenue | - | 1.39 x | 1.81 x | 2.42 x | 1.69 x | 1.39 x | 1.24 x |
| EV / Revenue | - | 1.39 x | 1.81 x | 2.42 x | 1.59 x | 1.26 x | 1.21 x |
| EV / EBITDA | - | 15.9 x | 17.9 x | 25.9 x | 18 x | 14.7 x | 13 x |
| EV / FCF | - | - | - | - | 52.1 x | 18.7 x | - |
| FCF Yield | - | - | - | - | 1.92% | 5.36% | - |
| Price to Book | - | - | 10.1 x | - | 9.49 x | 6.99 x | 7.23 x |
| Nbr of stocks (in thousands) | 106,252 | 108,126 | 109,466 | 111,704 | 112,538 | - | - |
| Reference price 2 | 47.80 | 145.4 | 240.6 | 349.5 | 279.5 | 279.5 | 279.5 |
| Announcement Date | 21-03-30 | 22-03-09 | 23-02-23 | 24-03-04 | - | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 11,281 | 14,565 | 16,144 | 18,662 | 22,681 | 25,275 |
| EBITDA 1 | - | 991.3 | 1,469 | 1,507 | 1,651 | 1,943 | 2,344 |
| EBIT 1 | - | 492.3 | 861.9 | 805.6 | 894.4 | 1,244 | 1,382 |
| Operating Margin | - | 4.36% | 5.92% | 4.99% | 4.79% | 5.48% | 5.47% |
| Earnings before Tax (EBT) 1 | - | - | 882.3 | 841.8 | 1,110 | 1,362 | - |
| Net income 1 | 194.3 | - | 700.1 | 666 | 888 | 1,090 | - |
| Net margin | - | - | 4.81% | 4.13% | 4.76% | 4.81% | - |
| EPS 2 | 1.798 | 3.615 | 6.180 | 5.770 | 6.558 | 9.232 | 10.01 |
| Free Cash Flow 1 | - | - | - | - | 570 | 1,536 | - |
| FCF margin | - | - | - | - | 3.05% | 6.77% | - |
| FCF Conversion (EBITDA) | - | - | - | - | 34.52% | 79.03% | - |
| FCF Conversion (Net income) | - | - | - | - | 64.19% | 140.81% | - |
| Dividend per Share 2 | - | - | 3.827 | - | 4.184 | 5.118 | 6.040 |
| Announcement Date | 21-03-30 | 22-03-09 | 23-02-23 | 24-03-04 | - | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 3,965 | 3,614 | 3,792 | 3,814 | 4,074 | 4,054 | 4,201 | 4,366 | 4,897 | 5,084 | 5,266 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | 300.2 | 208.1 | 214.4 | 187.3 | 205.2 | 196.2 | 216.8 | 223.4 | 276 | 276 | 312 |
| Operating Margin | - | 7.57% | 5.76% | 5.65% | 4.91% | 5.04% | 4.84% | 5.16% | 5.12% | 5.64% | 5.43% | 5.92% |
| Earnings before Tax (EBT) 1 | - | 307.7 | 214 | 211.4 | 198 | 211.7 | 203.2 | 228.9 | 231.5 | 281.5 | 280.5 | 316.5 |
| Net income 1 | 118 | 244.4 | 169.3 | 168.3 | 156.8 | 166.8 | 163.5 | 178.9 | 185 | 225 | 224.5 | 253.5 |
| Net margin | - | 6.16% | 4.69% | 4.44% | 4.11% | 4.09% | 4.03% | 4.26% | 4.24% | 4.59% | 4.42% | 4.81% |
| EPS 2 | 1.043 | 2.174 | 1.506 | 1.458 | 1.417 | 1.441 | 1.440 | 1.540 | 1.780 | 2.190 | 2.270 | 2.450 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 22-05-12 | 22-08-11 | 22-11-11 | 23-02-23 | 23-05-12 | 23-08-10 | 23-11-10 | 24-03-04 | - | - | - | - |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | - | - | - | 1,743 | 2,808 | 987 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | - | 570 | 1,536 | - |
| ROE (net income / shareholders' equity) | - | - | 30.9% | - | 23.7% | 25.2% | 27.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | 7.55% | 8.1% | - |
| Assets 1 | - | - | - | - | 11,762 | 13,463 | - |
| Book Value Per Share 2 | - | - | 23.80 | - | 29.50 | 40.00 | 38.70 |
| Cash Flow per Share 2 | - | - | - | - | 14.30 | 17.50 | 21.30 |
| Capex 1 | - | - | 303 | - | 1,004 | 381 | 638 |
| Capex / Sales | - | - | 2.08% | - | 5.38% | 1.68% | 2.52% |
| Announcement Date | 21-03-30 | 22-03-09 | 23-02-23 | 24-03-04 | - | - | - |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
279.5
TWD
Average target price
261.9
TWD
Spread / Average Target
-6.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -20.03% | 984M | |
| -13.23% | 3.49B | |
| -6.66% | 3.17B | |
| -24.46% | 3.13B | |
| +21.34% | 2.9B | |
| -8.42% | 1.78B | |
| +10.93% | 1.4B | |
| -37.30% | 707M | |
| -0.53% | 460M | |
| +5.39% | 403M |
- Stock Market
- Equities
- 6469 Stock
- Financials Great Tree Pharmacy Co., Ltd.